EMERYVILLE, Calif. (AP) _ Zogenix Inc. (ZGNX) on Monday reported a loss of $54.9 million in its fourth quarter.

On a per-share basis, the Emeryville, California-based company said it had a loss of 98 cents.

The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 90 cents per share.

The drugmaker posted revenue of $26.6 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $26.2 million.

For the year, the company reported a loss of $227.4 million, or $4.07 per share. Revenue was reported as $81.7 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZGNX at https://www.zacks.com/ap/ZGNX

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News